{
    "clinical_study": {
        "@rank": "30219", 
        "arm_group": [
            {
                "arm_group_label": "Dexamethasone group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to investigate the effects of dexamethasone on\n      inflammatory reactions after uterine artery embolization. The secondary purpose of this\n      study it to investigate the effects of dexamethasone on postembolization syndrome (severe\n      pain, nasea and vomiting)."
        }, 
        "brief_title": "Use of Dexamethasone in Uterine Artery Embolization", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Uterine Myoma", 
            "Adenomyosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Myoma", 
                "Leiomyoma", 
                "Myofibroma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Uterine artery embolization due to multiple myoma or adenomyosis\n\n        Exclusion Criteria:\n\n          -  Diabetic mellitus\n\n          -  Steroid administration\n\n          -  Liver or kidney dysfuntion\n\n          -  High baseline CRP or leukocytosis (>11,000/\u03bcL )\n\n          -  Drug allergy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "64", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02056717", 
            "org_study_id": "4-2013-0863"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dexamethasone group", 
                "description": "Administration of dexamethasone 10 mg IV 1 h before UAE", 
                "intervention_name": "Dexamethasone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Administration of normal saline 2 mL IV 1 h before UAE", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 5, 2014", 
        "location": {
            "contact": {
                "email": "KIMSY326@yuhs.ac", 
                "last_name": "So Yeon Kim, MD, PhD", 
                "phone": "82-2-2227-4470"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Dexamethasone on Inflammatory Response After Uterine Artery Embolization", 
        "overall_contact": {
            "email": "KIMSY326@yuhs.ac", 
            "last_name": "So Yeon Kim, MD, PhD", 
            "phone": "82-2-2227-4470"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "CRP, WBC, neutrophil (%), prolactin, cortisol : pre-UAE, post-UAE 12 h, post-UAE-24 h IL-6 : pre-UAE, post-UAE-24 h", 
            "measure": "Inflammatory reactions", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02056717"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Severance Hospital", 
            "investigator_full_name": "So Yeon Kim", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Immediately after UAE, post-UAE 1, 2, 4, 6, 8, 12, 24 h", 
                "measure": "Pain", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Immediately after UAE, post-UAE 1, 2, 4, 6, 8, 12, 24 h", 
                "measure": "Nausea and vomiting", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Severance Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Severance Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}